Skip to main content
. 2022 Nov 22;15:89. doi: 10.1186/s40545-022-00487-z

Table 3.

Factors that may affect drug demand patterns during COVID-19 in Yemen as perceived by the participants (N = 330)

Drug categories Pharmacy parameters cross-tabulated with the drug demand patterns
Pharmacy type District category
Community Hospital Unstable districts Front-line districts
1. Antibiotics
 Increased 95.6 (218) 94.3 (66) 96.0 (240) 92.5 (74)
 Unchanged 4.4 (10) 5.7 (4) 4.0 (10) 7.5 (6)
 P value 0.746* 0.232*
 Pearson Chi-square value 0.211 1.609
2. Antivirals
 Increased 25.9 (59) 35.7 (25) 30.8 (77) 25.0 (20)
 Unchanged 74.1 (169) 64.3 (45) 69.2 (173) 75.0 (60)
 P value 0.110* 0.526*
 Pearson Chi-square value 2.560 1.40
3. Antimalarials
 Increased 64.5 (147) 52.9 (37) 60.0 (150) 65.0 (52)
 Unchanged 35.8 (81) 47.1 (33) 40.0 (100) 35.0 (28)
 P value 0.08* 0.652#
 Pearson Chi-square value 3.060 1.271
4. Anxiolytics and sedatives
 Increased 70.2 (160) 70.0 (49) 71.2 (178) 68.7 (55)
 Unchanged 29.8 (68) 30.0 (21) 28.8 (72) 31.3 (25)
 P value 0.978# 0.675#
 Pearson Chi-square value 0.001 0.175
5. Antithrombotic
 Increased 66.2 (151) 64.3 (45) 67.2 (168) 66.3 (53)
 Unchanged 33.8 (77) 35.7 (25) 32.8 (82) 33.7 (27)
 P value 0.764# 0.875#
 Pearson Chi-square value 0.090 0.025
6. Analgesics and antipyretics
 Increased 99.1 (226) 98.6 (69) 99.2 (248) 97.5 (78)
 Unchanged 0.9 (1) 1.4 (2) 0.8 (2) 2.5 (2)
 P value 0.554* 0.248*
 Pearson Chi-square value 0.163 1.463
7. Vitamins and supplements
 Increased 94.7 (216) 85.7 (60) 94.0 (235) 90.0 (72)
 Unchanged 5.3 (12) 14.3 (10) 6.0 (15) 10.0 (8)
 P value 0.012# 0.221#
 Pearson Chi-square value 6.376 1.496
8. Ondansetron with antimalarials or macrolides
 Increased 83.7 (169) 82.5 (52) 87.7 (192) 75.3 (55)
 Unchanged 16.3 (33) 17.5 (11) 12.3 (27) 24.7 (18)
 P value 0.924* 0.026#
 Pearson Chi-square value 12.787 7.310

*p values were calculated using Fisher's exact test, #p values were calculated using Pearson Chi-square test